Regional Medical Research Centre, Indian Council of Medical Research, Department of Health Research, Government of India, Port Blair, Andaman & Nicobar Islands,India.
Chirayu Child Care Centre,Port Blair, Andaman & Nicobar Islands,India.
Epidemiol Infect. 2015 Feb;143(3):470-7. doi: 10.1017/S0950268814000958. Epub 2014 Apr 24.
This study is a part of the surveillance study on childhood diarrhoea in the Andaman and Nicobar Islands; here we report the drug resistance pattern of recent isolates of Shigella spp. (2006-2011) obtained as part of that study and compare it with that of Shigella isolates obtained earlier during 2000-2005. During 2006-2011, stool samples from paediatric diarrhoea patients were collected and processed for isolation and identification of Shigella spp. Susceptibility to 22 antimicrobial drugs was tested and minimum inhibitory concentrations were determined for third-generation cephalosporins, quinolones, amoxicillin-clavulanic acid combinations and gentamicin. A wide spectrum of antibiotic resistance was observed in the Shigella strains obtained during 2006-2011. The proportions of resistant strains showed an increase from 2000-2005 to 2006-2011 in 20/22 antibiotics tested. The number of drug resistance patterns increased from 13 in 2000-2005 to 43 in 2006-2011. Resistance to newer generation fluoroquinolones, third-generation cephalosporins and augmentin, which was not observed during 2000-2005, appeared during 2006-2011. The frequency of resistance in Shigella isolates has increased substantially between 2000-2006 and 2006-2011, with a wide spectrum of resistance. At present, the option for antimicrobial therapy in shigellosis in Andaman is limited to a small number of drugs.
本研究为安达曼和尼科巴群岛儿童腹泻监测研究的一部分,现报道 2006-2011 年该研究中获得的志贺菌最近分离株的耐药模式,并与 2000-2005 年获得的志贺菌分离株耐药模式进行比较。2006-2011 年,收集儿科腹泻患儿的粪便标本,进行志贺菌的分离和鉴定。检测 22 种抗菌药物的敏感性,并测定三代头孢菌素、喹诺酮类、阿莫西林-克拉维酸复方制剂和庆大霉素的最低抑菌浓度。2006-2011 年获得的志贺菌菌株表现出广泛的抗生素耐药性。在 22 种检测抗生素中,耐药菌株的比例在 2000-2005 年至 2006-2011 年间呈上升趋势。耐药模式的数量从 2000-2005 年的 13 种增加到 2006-2011 年的 43 种。在 2000-2005 年未观察到的新型氟喹诺酮类、三代头孢菌素和复方阿莫西林-克拉维酸的耐药性在 2006-2011 年出现。2000-2006 年和 2006-2011 年之间,志贺菌分离株的耐药频率显著增加,耐药谱广泛。目前,安达曼的志贺菌病抗菌治疗的选择有限,只有少数几种药物。